Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin for Pseudophakic Macular Edema
NCT00406172Phase 3Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Nov 2006
- Primary completion
- Nov 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in cystoid macular edema (CME), sponsored by Asociación para Evitar la Ceguera en México. Planned start Nov 2006; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00406172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406172.